APA (7th ed.) Citation

Longo, R., Llorens, M., Goetz, C., Platini, C., Eid, N., Sellies, J., . . . Quétin, P. (2017). Taurolidine/Citrate Lock Therapy for Primary Prevention of Catheter-Related Infections in Cancer Patients: Results of a Prospective, Randomized, Phase IV Trial (ATAPAC). Oncology, 93(2), 99. https://doi.org/10.1159/000470911

Chicago Style (17th ed.) Citation

Longo, Raffaele, Mathieu Llorens, Christophe Goetz, Christian Platini, Nada Eid, Jocelyne Sellies, Nadia Ouamara, and Philippe Quétin. "Taurolidine/Citrate Lock Therapy for Primary Prevention of Catheter-Related Infections in Cancer Patients: Results of a Prospective, Randomized, Phase IV Trial (ATAPAC)." Oncology 93, no. 2 (2017): 99. https://doi.org/10.1159/000470911.

MLA (9th ed.) Citation

Longo, Raffaele, et al. "Taurolidine/Citrate Lock Therapy for Primary Prevention of Catheter-Related Infections in Cancer Patients: Results of a Prospective, Randomized, Phase IV Trial (ATAPAC)." Oncology, vol. 93, no. 2, 2017, p. 99, https://doi.org/10.1159/000470911.